‘Opioids’ Is Missing From The US FDA’s Overdose Prevention Framework Title On Purpose
Executive Summary
Unlike prior plans, the FDA’s new substance abuse framework is intended to deal with stimulant and benzodiazepine use disorders, in addition to opioid abuse.